Rachel Bedenis Forster
Post doc
Contact
Send email {model.translations.sendEmailTo} RachelBedenis.Forster@fhi.no
Department
Responsibilities
Chronic disease epidemiology, cardiovascular disease
Projects and publications
- Jannicke Igland, Rachel Bedenis Forster, Anne Karen Jenum, Ragnhild Bjarkøy Strandberg, Tore Julsrud Berg, Jan Ivar Røssberg, Marjolein M. Iversen, Esben Selmer Buhl, (2024). How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registry-based cohort study from Norway. BMJ Open doi: 10.1136/bmjopen-2023-077027
- Camilla Kjellstadli, Rachel Bedenis Forster, Tor Åge Myklebust, Tone Bjørge, Kaare Harald Bønaa, Svein Inge Helle, Rune Kvåle, (2023). Cardiovascular outcomes after curative prostate cancer treatment: A population-based cohort study. Frontiers in Oncology s. 1-11. doi: 10.3389/fonc.2023.1121872
- Rachel Bedenis Forster, Camilla Kjellstadli, Tor Åge Myklebust, Grace M. Egeland, Gerhard Sulo, Tone Bjørge, Kaare Harald Bønaa, Pétur Benedikt Juliusson, Rune Kvåle, (2022). Treatment and 30-Day Mortality after Myocardial Infarction in Prostate Cancer Patients: A Population-Based Study from Norway. Cardiology s. 83-92. doi: 10.1159/000527636
- Ragnhild Bjarkøy Strandberg, Roy Miodini Nilsen, Frans Pouwer, Jannicke Igland, Rachel Bedenis Forster, Anne Karen Jenum, Esben Selmer Buhl, Marjolein Memelink Iversen, (2022). Lower education and immigrant background are associated with lower participation in a diabetes education program - Insights from adult patients in the Outcomes & Multi-morbidity In Type 2 diabetes cohort (OMIT). Patient Education and Counseling s. 1-7. doi: 10.1016/j.pec.2022.107577
- Rachel Bedenis Forster, Ragnhild Bjarkøy Strandberg, Katrina Louise Bø Tibballs, Kjersti Nøkleby, Tore Julsrud Berg, Tor Iversen, Terje P. Hagen, Kåre Rønn Richardsen, John Cooper, Sverre Sandberg, Karianne Fjeld Løvaas, Roy Miodini Nilsen, Marjolein M. Iversen, Anne Karen Jenum, Esben Selmer Buhl, (2022). Cohort profile: Outcomes & Multi-morbidity In Type 2 diabetes (OMIT) - a national registry-based observational cohort with focus on care and treatment of key high-risk groups in Norway. BMJ Open doi: 10.1136/bmjopen-2021-054840
- Rachel Bedenis Forster, Anders Engeland, Rune Kvåle, Vidar Hjellvik, Tone Bjørge, (2022). Association between medical androgen deprivation therapy and long-term cardiovascular disease and all-cause mortality in nonmetastatic prostate cancer. International Journal of Cancer s. 1109-1119. doi: 10.1002/ijc.34058
- Tamara Brown, Rachel Bedenis Forster, Marcus Cleanthis, Dimitri P Mikhailidis, Gerard Stansby, Marlene Stewart, (2021). Cilostazol for intermittent claudication. Cochrane Database of Systematic Reviews doi: 10.1002/14651858.CD003748.pub5
- Rune Kvåle, Kaare Harald Bønaa, Rachel Bedenis Forster, Kirsten Midttun Gravningen, Pétur Benedikt Juliusson, Tor Åge Myklebust, (2020). Hva betyr tidligere hjerte- og karsykdom eller kreft for risiko for død etter påvist SARS-CoV-2?. Tidsskrift for Den norske legeforening (Tidsskriftet) s. 135-140. doi: 10.4045/tidsskr.20.0956
- Ester Anne Kringeland, Gunhild Forland Slungård, Rachel Bedenis Forster, Rupali Rajendra Akerkar, Solveig Helene Warhuus Eriksen, (2023). Hjerte- og karregisteret - Rapport for 2022 .
- Rune Kvåle, Gunhild Forland Slungård, Rachel Bedenis Forster, Truc Trung Nguyen, Solveig Helene Warhuus Eriksen, (2022). Hjerte- og karregisteret • Rapport for 2012–2021.
- Ragnhild Bjarkøy Strandberg, Roy Miodini Nilsen, Francois Pouwer, Jannicke Igland, Rachel Bedenis Forster, Anne Karen Jenum, Esben Selmer Buhl, Marjolein M. Iversen, (2024). Associations of immigrant background and diabetes start course participation in individuals with type 2 diabetes in Norway – a study from the OMIT-cohort.
- Esben Selmer Buhl, Jannicke Igland, Rachel Bedenis Forster, Anne Karen Jenum, Ragnhild Bjarkøy Strandberg, Tore Julsrud Berg, Jan Ivar Røssberg, Marjolein M. Iversen, (2023). Prediction of mortality and validation of the ATC-code based Rx-risk comorbidity index in the “Outcomes & Multi-Morbidity In Type 2 diabetes” (OMIT) cohort. .
- Jannicke Igland, Rachel Bedenis Forster, Anne Karen Jenum, Ragnhild Bjarkøy Strandberg, Tore Julsrud Berg, Jan Ivar Røssberg, Marjolein M. Iversen, Esben Selmer Buhl, (2022). The validity of the Rx-risk comorbidity index among adults in the Outcomes & Multimorbidity in Type 2 diabetes cohort (OMIT).
- Ragnhild Bjarkøy Strandberg, Roy Miodini Nilsen, Frans Pouwer, Jannicke Igland, Rachel Bedenis Forster, Anne Karen Jenum, Esben Selmer Buhl, Marjolein M. Iversen, (2022). Associations of immigrant background and diabetes start course participation in adults with type 2 diabetes in Norway - a study from the OMIT-cohort.
- Ragnhild Bjarkøy Strandberg, Roy Miodini Nilsen, Francois Pouwer, Jannicke Igland, Rachel Bedenis Forster, Anne Karen Jenum, Esben Selmer Buhl, Marjolein M. Iversen, (2022). Participation in diabetes educational programs in adults with type 2 diabetes in Norway: whom are we reaching?.
- Rachel Bedenis Forster, Camilla Kjellstadli, Tor Åge Myklebust, Rune Kvåle, (2021). Myocardial infarction after prostate cancer diagnosis in Norway: a population-wide registry-based study. European Heart Journal s. 2852-2852. doi: 10.1093/eurheartj/ehab724.2852
- Rachel Bedenis Forster, Tor Åge Myklebust, Kirsten Midttun Gravningen, Rune Kvåle, (2021). Increased risk of COVID-19-associated death in people under 70 with cardiovascular disease compared to the general population- A nationwide, registry-based study from Norway. European Heart Journal s. 3135-3135. doi: 10.1093/eurheartj/ehab724.3135